















An evaluation of the impact of mHealth interventions on patients’ 
attendance to treatment for three common ophthalmic diseases 
that cause blindness: a systematic review 
 
 
Meftah Mohamed Mohamed Madi 
 MDXMEF001 
Supervisor: Dr Jill Abrahams  
Co-superv sor: Prof. Tania Douglas 
 
Minor Dissertation in partial fulfilment of the requirements for the degree of 
Master of Philosophy in Health Innovation 
 
Division of Biomedical Engineering, Faculty of Health Sciences, University of 
Cape Town 
 



















The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 




The copyright of this thesis vests in the author. No quotation 
from it or information derived from it is to be published without 
full acknowledgement of the source. The thesis is to be used for 
private study or non-commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms of 




I, Meftah Madi, hereby declare that the work that I have submitted is based on my own original 
work and has not, in whole or in part, been submitted towards another degree at this university 
or elsewhere. Where the work of others has been used (whether quoted verbatim, paraphrased, 
or referred to) it has been attributed and acknowledged. 
I empower the university to reproduce for the purpose of research either the whole or any 
portion of the contents in any manner whatsoever. 
Signature: 





Ophthalmic diseases are those that affect the eye, including cataracts, glaucoma, age-related 
macular degeneration and diabetic retinopathy. These diseases can lead to blindness and vision 
loss, especially at advanced stages. Cataracts, glaucoma and diabetic retinopathy are the most 
common ophthalmic diseases that cause blindness. Patients encounter challenges with 
attendance to appointments for treatment because they may forget the date, time and/or place 
of the surgery. mHealth interventions are a means of addressing the challenge of patients 
missing appointments. This study reviews the use of mHealth reminders to improve patients’ 
attendance to ophthalmic disease treatment. 
Methods: 
A systematic review was conducted to assess the literature from various databases including; 
PubMed, Scopus, (Africa-Wide Information, CINAHL, Computers & Applied Sciences 
Complete, Health Source: Nursing/Academic Edition by Ebscohost) and Web of Science. We 
searched different sources for grey literature including; Google.com, Open Grey, New York 
Academy of Medicine, WHO, Cochran library, and Cochrane Central Register of Controlled 
Trials. The interventions were limited to SMS and telephone calls. Studies were considered 
eligible if they were randomized control trials (RCT), prospective or retrospective cohort 
studies, cross-sectional studies, or if they reported on outcomes primarily related to patient 
attendance to ophthalmic disease appointments.  
Results 
Ten studies that met the eligibility criteria were included in the systematic review. The study 
setting included developed countries and low-and-middle-income countries (LMIC). Sixty 
percent of these studies were conducted in LMIC, while forty percent were conducted in 
developed countries. Eighty percent of the study participants were older than 55 years and the 
mean age of participants was 61.5 years. Both male and female participants were included, 
with approximately fifty nine percent of them being female. 
Discussion 
The assessment of the literature highlighted that mHealth reminders resulted in significant 
improvement in patient attendance to treatment for the three common ophthalmic diseases. The 
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mHealth platform was particularly relevant in LMIC, and SMS was the most successful 
intervention. Women were the major users of mHealth tools to gain access to services.  
Conclusion:  
This systematic review aimed to inform healthcare workers and decision makers in the health 
system on the use of mobile phone messaging as reminders to improve patient attendance to 
the three common ophthalmic diseases treatments that cause blindness. The evidence obtained 
from the systematic review will bring new opportunities for further research regarding the use 
of mHealth interventions as reminders for treatment adherence in general and ophthalmic 
diseases such as cataracts, glaucoma and diabetic retinopathy. 
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1.  Chapter One: Introduction 
1.1. Background  
Ophthalmic diseases are prevalent worldwide, especially in elderly patients (Whitcher et al., 
2001). Such diseases include cataracts, glaucoma, age-related macular degeneration (AMD) 
and diabetic retinopathy. These diseases lead to blindness and vision loss (Whitcher et al., 
2001, Mitchell and Bradley, 2006). Cataract, glaucoma and diabetic retinopathy are the three 
most common eye diseases that cause blindness  (Pelletier et al., 2016, Naidoo et al., 2014). In 
most advanced cases of eye disease, urgent surgery is required to avoid blindness (Boyd, 2014). 
Cataract is the most common ophthalmic disease affecting people globally (Brian and Taylor, 
2001) and is considered the leading cause of blindness in the world (Bourne et al., 2013, 
Thavikulwat et al., 2015). According to the World Health Organization (WHO), the latest 
assessment in cataract blindness in 2010 was that cataract is responsible for 51% of world 
blindness, which represents approximately 20 million people (WHO, 2010). Cataract surgery 
is considered the only treatment for cataract disease. 
  
In developing countries, cataract patients have difficulty gaining access to surgery and surgical 
facilities due to many factors. These factors including lack of awareness of the disease itself, 
lack of transport specifically for people who live in rural areas, and socio-economic conditions 
(Wearne, 2007). Vision loss associated with glaucoma is preventable with adherence to eye 
care medication and treatments (Quigley and Broman, 2006). Similarly, for diabetic 
retinopathy, a key factor for management is provision of and adherence to follow-up treatments 
(WHO, 2007).  The reasons for the missed appointments include: forgetting the time of the 
appointment, misunderstanding the date, losing the address for the appointment, lack of 
communication, limited access to transport, cost, and culture (Malherbe, 2017, Cate et al., 
2013, Mumba et al., 2007). Missing an appointment can lead to delays in treatment (Murray, 
2000). 
Many conventional methods have been used as reminders for general health diseases such as 
posted letters and appointment cards (Reekie and Devlin, 1998). However, interventions like 
mobile phone messaging has been shown in to improve attendance rates of patients to cataract 
surgery (Lin et al., 2012, Sanguansak et al., 2017). In addition, mobile phone messaging has 
improved patients’ compliance to health care appointments for glaucoma (Pizzi et al., 2016).  
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Mobile phone messaging is a form of mobile health (mHealth). mHealth aims to address 
healthcare delivery by use of mobile telecommunication and multimedia technologies as an 
approach to fill the accessibility gap between patients and health professionals. mHealth has 
the potential to improve patient-provider communication, health promotion and disease 
management (Beratarrechea et al., 2014).  
In developing countries, mHealth is used to address the problem of a limited healthcare 
workforce (Beratarrechea et al., 2014). WHO has suggested that mHealth can change the form 
of health service delivery worldwide (WHO, 2011). Recently, mobile phones and the internet 
are being used to offer various services to improve healthcare delivery; these services include 
voice and text communication (Beratarrechea et al., 2014). Mobile technologies provide access 
to healthcare professionals by facilitating immediate communication and faster decision-
making by health workers since they can access information more easily through advanced 
mobile computing (Varshney, 2014). The use of smartphones by ophthalmologists is wide-
spread globally (Bastawrous et al., 2012). In an investigation of mobile phone ownership, 99% 
of health professionals were found to own a mobile phone, with 81% of these being a 
smartphone (Beratarrechea et al., 2014).  
The available literature on mHealth shows benefits in the use of mHealth for several diseases, 
but little is known on the use of mHealth for ophthalmic diseases such as cataract surgery. 
mHealth is shown as beneficial for diseases such as diabetes (Jin et al., 2004), HIV/AIDS 
(Fairley et al., 2003), and smoking cessation (Fairhurst and Sheikh, 2008). mHealth has shown 
impact on chronic diseases in LMIC (Beratarrechea et al., 2014). However, limited research 
has been conducted on the use of mHealth in cataract diseases. Therefore, this study aimed to 
evaluate the use of mHealth interventions as a reminder to improve patient attendance to 
ophthalmic disease treatments through a systematic review methodology. The systematic 
review focused on studies that have investigated mobile phone messaging as a way of 
encouraging patients to attend ophthalmic diseases treatment appointments. The evidence from 
this study would assist in devising strategies to improve attendance to appointments for 
ophthalmic disease treatments. 
1.2. Aim and research question 
The aim of the study was to evaluate the impact of mHealth interventions on patients’ 
attendance to appointments for treatment of ophthalmic diseases that cause blindness. 
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The following research question was addressed: In patients with the three common ophthalmic 
diseases that cause blindness, do mHealth reminders have an effect on patient attendance to 
ophthalmic disease treatment appointments compared to conventional reminders? 
The Patient Intervention Comparator and Outcome (PICO) were as follows: 
P: The participants were patients with the three common ophthalmic diseases that cause 
blindness.  
I: The intervention was mHealth intervention as a reminder. 
C: The comparator was conventional reminders.  
O: The outcome was patient’s attendance to ophthalmic disease treatment appointments. 
1.3. Dissertation outline  
The dissertation is organized as follows, Chapter One reviews general background information 
about ophthalmic disease including cataract, glaucoma and diabetic retinopathy as the main 
three diseases led to blindness and poor representation of these disease to treatments adherence. 
also, presents the research question, aim and objectives of the study.  
Chapter Two reviews the available literature on the topic of study. It contextualizes ophthalmic 
disease and outlines its prevalence from a global perspective. The review engages with the 
literature on mHealth as a tool that is used in offering health solutions. The final aspect is the 
evaluation of the relationship between mHealth and ophthalmic diseases.  
Chapter Three describes the systematic review methods that were applied in the study. It 
explains the systematic review components including eligibility criteria, search strategy, data 
extraction, study selection, assessing risk of bias, data analysis and synthesis. It offers methods 
of dealing with missing data and assessing heterogeneity.  
Chapter Four presents the results of the systematic review, including study selection, study 
characteristics, risk of bias in included studies and results of individual studies.  
Chapter Five offers a discussion of the results and the limitations of the study. It also considers 
the impact of the results. In addition, it provides a conclusion and recommendations for further 
studies with regard to use of mHealth in ophthalmic diseases. 
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2. Chapter Two: Literature Review 
This chapter reviews the available literature regarding cataracts and mHealth. It contextualizes 
ophthalmic diseases and outlines its prevalence from a global perspective as well as in 
developing countries. The chapter highlights some of the challenges that limit patient access to 
cataract surgery. Examples are provided of the benefits of the use of mHealth in the health care 
system and in the management of cataract, glaucoma and diabetic retinopathy. 
2.1. Cataract 
Cataracts are an opacification of the lens or its capsule (Lin and Michaelson, 2013). This 
prevents clear vision, and occurs as a result of advancement in age, natural occurrences such 
birth with cataract, traumatic experiences such as injuries, inflammation, or other eye diseases 
(WHO, 2010). There are many instances of minor lens opacities which do not substantively 
interfere with the vision of an individual, such as those that are able to absorb or deflect the 
light rays entering the eye, and consequently produce a distorted image on the retina 
(Hejtmancik, 2008). About 85% of cataracts are classified as senile or mature and a substantial 
proportion of these are associated with diabetes (Gupta et al., 2014). Diabetic patients are more 
likely to develop cataracts at an earlier age than patients who are not diabetic (Devgan, 2010). 
Varying statistics from international, regional and country perspectives are instructive in 
assisting in our appreciation of cataracts. Historical numbers indicate that 47.8 per cent of 
persons globally are affected by cataract (Murthy et al., 2008). In 1990 it was estimated that 37 
million people were blind worldwide, and 40 per cent of this number was attributed to cataracts 
(Thylefors et al., 1995, Allen and Vasavada, 2006). Contemporary projections indicate that 
since the population over the age of 60 years will stand at 120 million in 2020, the increase in 
the elderly population will lead to higher numbers with poor vision and blindness as a result of 
cataracts (Khairallah et al., 2015).  
The WHO has estimated that over 20 million people already suffer from cataract blindness, 
and this number can be expected to grow with a rapidly aging population (WHO, 2017). 
Blindness from cataracts is considered to be one of the prevalent health challenges of the 21st-
century (Brian and Taylor, 2001). Women are disproportionately affected by cataract insofar 
as they form the largest number of persons over 65 years who are affected (UN, 2015). In 
addition, the majority of the affected elderly people are living in Asia, Africa and America 
(WPPR, 2015).  
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Cataract has been reported to account for about 90% of the blindness in developing countries 
(Prokofyeva et al., 2013). In these countries cataract blindness has an association with disability 
and mortality, which is of economic and social concern (Frick and Foster, 2003). In developed 
countries, cataracts are responsible for 50% of the blindness (Lawani et al., 2007). The 
incidence of cataracts is associated with older age, low income, lower education and also with 
diseases such as hypertension and diabetes (Park et al., 2016). In South Africa, statistics 
indicate that cataract is the leading cause of blindness. Also, it is envisaged that cataract surgery 
has to be carried out on a minimum of two thousand people per million population per year for 
elimination of cataract blindness (Lecuona, 2011).  
There are some similarities between cataract and other ophthalmic diseases such as diabetic 
retinopathy and glaucoma. For instance, all lead to blindness and require surgery for treatment 
(Pelletier et al., 2016). Early diagnosis and treatment are critical to prevent blindness in patients 
with diabetic retinopathy and glaucoma (Quillen, 1999, Pelletier et al., 2016). Patients may 
suffer from both cataract and glaucoma simultaneously; patients with glaucomic diseases who 
need surgery and have coexisting cataracts, may use the surgery as an opportunity to remove 
cataract. Those who need cataract surgery while their vision is affected by glaucoma, can also 
have both surgeries performed simultaneously (Grover, 2017).  
Table 1 presents the three most common ophthalmic diseases that result in blindness (Quillen, 
1999, Pelletier et al., 2016), and provides their causes, symptoms and treatment, thereby 













 Cataract Diabetic Retinopathy Glaucoma 
Definition Clouds on the lens of the eye which 
prevent sufficient light from reaching 
the retina (Boyd, 2014). 
Damage in blood vessels of the retina 
due to increased levels of blood 
sugar; swelling can prevent blood 
from passing through other parts of 
the retina (Saudek, 2008).  
Fluid build-up and high 
pressure affecting the 
optic nerve (Nordqvist, 
2017).  
Cause Aging is the most common cause: the 
proteins in the lens start to breakdown 
(Boyd, 2014).  
The main cause is increase blood 
glucose levels (Boyd, 2017). 
Tumor, diabetes, 
inflammation and 
advanced cataract are 
causes (Nordqvist, 
2017). 
Symptoms Sensitivity to light, double vision, 
blurry vision (Boyd, 2014).  
Spots or floaters, blurred vision, 
fluctuating vision, and impaired 
colour vision (Boyd, 2017). 
Redness of the eye, 
blurred vision, pain in 
the eye or forehead, and 
headache (Boyd, 2018).  
Treatment Traditional cataract surgery or laser 
assisted cataract surgery (Boyd, 2014).  
Drugs such as anti-vascular 
endothelial growth factor injection or 
laser surgery (Boyd, 2017).  
Eye drops to decrease 
eye pressure or laser 
surgery in advanced 
stages (Nordqvist, 2017) 
Table 1: Most prevalent ophthalmic diseases leading to blindness(Quillen, 1999, Pelletier et al., 2016). 
 
2.2. Cataract surgery  
The World Health Organization has emphasized access to quality cataract surgery as a top 
priority (WHO, 2010). The urban areas of most developing countries have health facilities that 
provide cataract surgery services in areas of high population density, in stark contrast with 
remote areas where access to cataract surgery is limited (Brian and Taylor, 2001). In 
developing countries, a low number of children with cataracts attend health care facilities for 
surgery compared to the burden of disease in the community (Bronsard et al., 2008). Access to 
cataract surgery is affected by various factors. These include socio-economic barriers to 
cataract surgery, which are more common in remote areas and include a lack of transport, 
communication, undeveloped health care facilities as well as poverty (Wearne, 2007).  
One of the challenges that adversely affect access to cataract surgery is missing appointments 
when the patients forget the time, date and address (Sawyer et al., 2002). Missing an 
appointment can lead to delays in treatment (Murray, 2000). Furthermore, lack of awareness 
of cataract surgery is a barrier (Bronsard et al., 2008). A lack of patient education by health 
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facilities affects the engagement of the patients to be booked for cataract surgery as well as 
post-operative follow-up (Chang et al., 2008). In addition to post-operative follow-up and 
monitoring, other challenges relate to the failure by patients to comply with medication (Brian 
and Taylor, 2001).  
Poverty is a key factor that contributes to the failure to have surgery (Kessy and Lewallen, 
2007). The low levels of cataracts in developed countries compared with the high levels of the 
same in developing countries is an indication of the effect of poverty (Resnikoff et al., 2004), 
and particularly affects the elderly in developing countries (Lewallen et al. (2009). Closely 
linked to poverty is the lack of infrastructure that is required to enable the surgery to take place. 
In Africa, the limited eye care services that are available are usually in cities. Also, 
transportation to such facilities from more rural areas becomes a challenge (Bowman et al., 
2000). 
In developing countries, the cost of cataract surgery is still the major limitation to reducing 
high rates of cataracts (Lee and Afshari, 2017). While the cost of cataract surgery may present 
a barrier to access, other attendant costs should be considered. These include the cost of 
transport to the hospital, loss of income by the patient for the days when they are not able to 
work, expenses when they are in hospital, and costs associated with having a caregiver after 
surgery and/or having a caregiver, family member, etc. to accompany the patient to surgery 
(Lewallen and Courtright, 2001).  
Lack of knowledge coupled with the various societal stereotypes are instructive in 
understanding why cataract surgery does not take place in instances where patients have access 
to surgery. Lack of knowledge with regard to the availability of the surgical services as well as 
the fact that cataract can be cured is a great obstacle to having the surgery (Hubley and Gilbert, 
2006). This lack of knowledge is usually fortified by the existence of cultural or societal beliefs 
that are used to explain the occurrence of cataract on an individual (Hubley and Gilbert, 2006). 
As a result, the society, community and individuals are prevented from appreciating the 
scientific methods that could be used to cure a disease (Balo et al., 2004). In South Africa, for 
instance, cultural and social barriers were found to prevent female patients from Limpopo in 
receiving cataract surgery. The reasons included; lower education levels, lack of social support, 
and patriarchal control of time and money among females compared with males (Ntsoane, 
2016). In addition, in LMIC women are more affected by cataracts in comparison to their male 




Closely related to the beliefs, the lack of knowledge is also exacerbated by the lack of trust in 
the process of the surgery. Some people fear that the surgery may be unsuccessful and lead to  
adverse consequences like blindness (Rotchford et al., 2002). As such the lack of trust in the 
system keeps the benefits of the surgery from the patients who would otherwise need it. 
2.3. mHealth  
mHealth refers to the use of telecommunication devices to support the health system and 
clinical practice (Kahn et al., 2010). It engages technological advances coupled with medical 
expertise, presenting new possibilities in major healthcare areas such as diagnostics, 
telemedicine, research, reference libraries and interventions (Bastawrous et al., 2013). It is 
supported by mobile devices, such as mobile phones, patient monitoring devices, personal 
digital assistants and other wireless devices (WHO, 2011). mHealth platforms include all 
computer and medical devices, internet and mobile phone devices (Free et al., 2013).  
mHealth aims to address healthcare delivery by use of mobile telecommunication and 
multimedia technologies as an approach to fill the accessibility gap between patients and health 
professionals. It has the potential to improve patient-provider communication, health 
promotion and disease management (Beratarrechea et al., 2014). Mobile technologies can 
provide access to healthcare professionals by facilitating immediate communication and can 
increase the level of decision-making by health workers through access to information through 
advanced mobile computing (Varshney, 2014). At its core, mHealth involves the use and 
capitalization on a mobile phone’s core utility of voice and short messaging service (SMS) as 
well as more complex functionalities and applications including general packet radio service, 
third and fourth generation mobile telecommunications (3G and 4G systems), global 
positioning system (GPS), and Bluetooth technology (Thuemmler et al., 2018).  
Mobile phone communication has been used as an essential approach to increase delivery of 
health services all over the world (Kaplan, 2006). In developing countries, mHealth has been 
used in an effort to address a limited healthcare workforce (Beratarrechea et al., 2014). 
Statistics show that while Africa bears 24% of the world’s disease burden, only 3% of the 
world’s health professionals are in Africa (Teke 2017). WHO has suggested that mHealth can 
change the form of health service delivery worldwide (WHO, 2011).  
mHealth has recently been beneficial in the control of the Zika virus by pinpointing outbreaks 
and helping physicians detect the virus (Dudley et al., 2017), and in the fight against the Ebola 
virus (Dahiya and Kakkar, 2016). Examples of mHealth in the form of text message 
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intervention include smoking termination (Fairhurst and Sheikh, 2008), increasing attendance 
at primary care appointments (Gurol-Urganci et al., 2013), improving adherence to medication 
(Fairley et al., 2003), and follow-up of chronic diseases (Ferrer-Roca et al., 2004). Test 
messaging has also been used as a means to control infectious diseases and for health promotion 
(Obermayer et al., 2004). Lin et al. (2012) have found that SMS reminders have improved 
follow-up attendance for pediatric cataracts, thereby proving to be a useful tool in controlling 
infant cataracts in China.  
Text messaging is considered the most common type of communication used between people 
(WHO, 2011). The SMS has been found cost effective and is efficient in reaching the patient 
regardless of the phone being switched off and in areas where phone calls are not allowed 
(Kaplan, 2006). Moreover, Balzer et al. (2014) found that SMS is a feasible tool for use as a 
reminder system. 
2.4. mHealth and ophthalmic diseases   
literature shows various examples of mHealth with ophthalmic diseases, for example, mHealth 
may aid in the use of cataract surgery. A two-way social media messaging app has been found 
to be useful in delivering post-operation information to cataract patients and is a feasible way 
for aiding early medication compliance. In addition, mHealth has been useful in assistances on 
post-operative follow-up for pediatric cataract patients (Lin et al., 2012, Sanguansak et al., 
2017). A mobile phone app has been used to help doctors with decision support before cataract 
surgery (Wicklund, 2016). With regards to glaucoma mHealth has been shown to have a 
significant effect on improving adherence to glaucoma appointments and medications (Saeedi 
et al., 2015). While these studies show the positive effects of mHealth in improving the 
management of ophthalmic disease, a few cases where there has been no effect also exist 
(Koshy et al., 2008, Mtuya et al., 2016).  However, of all the studies identified, few of them 
are RCTs. This lack of evidence in RCTs has therefore necessitated carrying out this study.   
2.5. Summary 
The literature has provided evidence that ophthalmic diseases treatment appointments are often 
missed due to forgetfulness, lack of communication, financial, cultural and societal barriers. 
mHealth has been used as a reminder in the health sector, for example in increasing attendance 





3. Chapter Three: Methodology  
This chapter describes the systematic review steps that were applied in the study, which was 
guided by the Preferred Reporting Items for Systematic Review and Meta-Analyses 
(PRISMA). The prism checklist is attached in Appendix A. 
3.1. Eligibility criteria for include studies 
3.1.1 Study design 
Randomized control trials (RCTs), non-randomized control trials (non RCTs) such as 
prospective and retrospective cohort studies and cross-sectional studies were included.  
3.1.2 Study participants 
We included all studies that used participants who have cataract, glaucoma and diabetic 
retinopathy who may require surgery in order to avoid blindness associated with those diseases 
regardless of their age, gender, religion or race and location.  
3.1.3 Type of intervention  
mHealth interventions included in the study were SMS and telephone calls to encourage 
patients to attend appointments for surgery or treatment. We excluded mobile phone 
applications that require access to the internet, such as multimedia message service and emails. 
These applications might not be accessible to all users, compared to SMS and phone calls, 
especially in LMIC.  
3.1.4 Outcomes 
The primary outcome was patient’s attendance to ophthalmic disease treatment appointments 
compared to conventional reminders. The secondary outcome was an evaluation of the cost of 
the reminders. 
3.1.5   Study setting 
There was no limit on the study setting and studies from all countries globally were included.  
3.2. Search strategy  
The search strategy was developed in consultation with a Health Sciences Information 
Specialist. We identified all relevant literature from the date of introduction of SMS text 
messaging on 3 December 1992 till 28 February 2018. Articles published in English and with 
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human targets were included (Deffree, 2015). A comprehensive search was conducted on 
PubMed, Scopus, (Africa-Wide Information, CINAHL, Computers & Applied Sciences 
Complete, Health Source: Nursing/Academic Edition by Ebscohost) and Web of Science. 
Specific search terms included free text and medical subject heading (MeSH). The search terms 
were adapted for different databases.  
 
The search terms that described mHealth, ophthalmic disease and reminder system were used 
the search strategy for PubMed is represented in Table 2. The reference lists of relevant studies 
were assessed by the first author and full-text articles were obtained and reviewed for further 
information collection. Grey literature sources were searched for in Google.com, Open Grey 
and New York Academy of Medicine, WHO, Cochran library, Cochrane Central Register of 
Controlled Trials. Identified unpublished literature was assessed using the same eligibility 




























(((((((((((((((((("Cataract"[Mesh]) OR Cataract) OR "Cataract Extraction"[Mesh]) OR Cataract 
Extraction) OR cataract surgery) OR cataract removal) OR "Lenses, Intraocular"[Mesh]) OR 
Lenses, Intraocular) OR "Aphakia, Postcataract"[Mesh]) OR Aphakia, Postcataract) OR 
"Pseudophakia"[Mesh]) OR Pseudophakia OR “glaucoma”[Mesh]) OR glaucoma OR open 
angle OR diabetic retinopathy )))))    AND ((((((((((((((((((((((((((((((("Telemedicine"[Mesh]) 
OR Telemedicine) OR mHealth) OR mobile health) OR "Wireless Technology"[Mesh]) OR 
Wireless Technology) OR "Mobile Applications"[Mesh]) OR Mobile Applications) OR "Cell 
Phones"[Mesh]) OR Cell Phones) OR cellular phone) OR telephones) OR mobile telephone) 
OR mobile phones) OR "Smartphone"[Mesh]) OR Smartphone) OR "Text Messaging"[Mesh]) 
OR Text Messaging) OR text messages) OR textings) OR messaging) OR short message 
service) OR voice mail) OR telephone call) OR phone call) OR Whatsapp) OR "Reminder 
Systems"[Mesh]) OR Reminder Systems) OR Reminder))))) AND (((((((((((("Patient 
Compliance"[Mesh]) OR Patient Compliance[Title/Abstract]) OR "No-Show Patients"[Mesh]) 
OR No-Show Patients[Title/Abstract]) OR Patient Non-Attendance[Title/Abstract]) OR "Lost 
to Follow-Up"[Mesh]) OR Lost to Follow-Up[Title/Abstract]) OR Attendance[Title/Abstract]) 
OR adherence[Title/Abstract])) OR cost effectiveness[Title/Abstract]) 
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Table 2: PubMed search strategy  
 
3.3. Data extraction 
Two researchers (MM and JF) extracted data from the eligible literature independently. 
Conflicts of view between the two researchers were resolved through discussion. When no 
agreement was reached, a third researcher intervened (TD). Key information extracted from 
the included studies were: 
1. Author/s and year of the study. 
2. Country of the study setting. 
3. Type of facility/environment (e.g. eye clinic, pediatric hospital, community). 
4. Association of an author. 
5. Type of participants / study population / demographic characteristics (e.g. 
children, gender, age and race). 
6. Type of mobile device users. 
7. Nature of the mHealth intervention. 
8. Type of study (i.e. study design). 
9. Type of outcomes measured. 
10. Findings / results. 
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Data was entered into Review Manager (RevMan) software, Version 5.1. by the authors (MM 
and JF) of this report. A second researcher verified the data entered for missing or incorrect 
information. Data extraction form is presented in Appendix C. 
3.4. Study selection 
The relevant studies extracted were saved into Endnote reference management software for 
further screening. Two researchers (MM and JF) screened the titles and abstracts of identified 
studies independently for eligibility. These researchers made the final assessment for inclusion 
using the full-text articles, while disagreements and conflicts were fixed by a third researcher 
(TD). Each author documented the reasons for exclusion of studies.  
3.5. Assessing risk of bias  
Risk of bias was assessed by two researchers (MM and JF) independently, and any 
disagreement was deliberated on and resolved in discussion with a third researcher (TD). This 
evaluation was based on criteria of the International Cochrane Collaboration (Likis et al., 2014) 
for RCTs i.e. randomization sequence generation, allocation concealment, blinding of 
participants, incomplete outcome data, selective outcome reporting and other sources of bias. 
Risk of bias in observational studies was assessed by using a tool for quality assessment of 
observational studies (Hoy et al., 2012). We stated our judgment of the risk of bias for each 
included study as low, high or unclear.  A descriptive summary for the risk of bias for each 
domain in each included study is provided in figure 3 and 4. 
3.6. Dealing with missing data  
Relevant missing data were identified, and the articles compared with published trial reports. 
Any discrepancies were resolved by contacting the original authors and if there was no 
response from the authors, incomplete data was discussed.  
3.7. Data analysis and synthesis  
This systematic review was to determine the impact of use of mHealth intervention on patient 
attendance to cataract surgery. The methodology for data analysis was guided by the Cochrane 
Handbook of Systematic Reviews for Interventions (Deeks et al., 2011). Data were analyzed 
using Review Manager software (RevMan). 
  
The results of each study were expressed as risk ratio with its corresponding 95% confidence 
interval (CI) for dichotomous data, or a mean difference with its 95% CI for continuous data. 
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The studies were gathered based on similar types of participants, interventions, study designs 
and outcomes for an overall estimate of effect. The data were pooled from studies of similar 
interventions, participants, outcomes and study designs in a meta-analysis using the random 
effects model if there is no significant statistical heterogeneity, methodological difference or 
high risk of bias. If variation between studies in the reported interventions, participants, study 
designs and outcome measures was encountered, we did not pool the results but summarized 
the results in a narrative format.  
3.8. Assessment of heterogeneity  
Clinical heterogeneity was measured by examining types of participants, interventions, and 
outcomes in each study. Those studies identified as being clinically homogenous were pooled. 
Heterogeneity between studies was evaluated using chi-square tests and I-squared statistics. 
We quantified any statistical heterogeneity between study results using the I² statistic. We 
regarded heterogeneity as considerable if the I² was greater than 50% (Higgins 2011). 
3.9. Ethics approval. 
There was on needs for ethics approval since the study did not involve human participants.  
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4. Chapter Four: Results 
This chapter presents results of the systematic review. 
Description of the studies. 
4.1. Result of the search   
Seventy studies were identified from the literatures searches. Ten studies were obtained from 
grey literature and the World Wide Web.  
Fifty-one articles were reviewed after all duplicates were removed where sixteen studies were 
excluded. Thirty-five full-text articles were reviewed for eligibility and twenty-five articles 
were excluded with reasons. Only ten studies were included in the quantitative synthesis. The 


























Figure 1: Visual representation of the study selection 
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4.2. Included studies  
Study design and setting. 
Ten studies were eligible and included in the review.  Four of the ten studies were RCTs (Lin 
et al., 2012, Pizzi et al., 2016, Malherbe, 2017, Yang et al., 2016). The remaining six studies 
were non-RCTs with three a cohort studies (Huang et al., 2012, Meltzer et al., 2017, Fudemberg 
et al., 2016), two a cross sectional studies (Mtuya et al., 2016, Saeedi et al., 2015) and one non 
RCT study ( Koshy et al 2008). 
Four studies were conducted in China (Lin et al., 2012, Huang et al., 2012, Meltzer et al., 2017, 
Yang et al., 2016), three studies in the USA (Saeedi et al., 2015, Fudemberg et al., 2016, Pizzi 
et al., 2016), one in the UK (Koshy et al., 2008), one in Tanzania (Mtuya et al., 2016) and one 
in South Africa (Malherbe, 2017).  
Four studies out of ten addressed cataracts surgery diseases (Lin et al., 2012, Huang et al., 
2012, Meltzer et al., 2017, Malherbe, 2017). Another four studies addressed glaucoma diseases 
(Fudemberg et al., 2016, Saeedi et al., 2015, Pizzi et al., 2016, Yang et al., 2016). The 
remaining two studies addressed diabetic retinopathy (Mtuya et al., 2016), and ophthalmology 
outpatient appointments (Koshy et al., 2008).  
4.3. Excluded studies  
The main reason for exclusion of studies based on title and abstract is that they did not focus 
on cataract or associated conditions. Other excluded studies focused on interventions other than 
mHealth (Ludbrook et al., 2015, Prinja et al., 2015), asthma diseases (Gillissen et al., 2007, 
McDonald Heiner, 2007), sight loss diseases (Khan et al., 2015) esotropia diseases (Costello 
et al., 2001), oral supplementation (Chew et al., 2015), chronic diseases (Lin and Wu, 2014), 
drug delivery (Paganelli et al., 2010), medication noncompliance (Morrissey et al., 2007) and 
global public health problems (Rao, 2015). 
The reasons for exclusion based on full-text review are presented in Appendix D.  One of the 
main reasons was that the intervention did not use reminders and also did not measure any of 
the outcomes of interest (Gale et al., 2004, Gale et al., 2006, Lin et al., 2016, Drews-Botsch et 
al., 2016, Lambert et al., 2016, Norregaard, 2007, Hoffman and Pelosini, 2016, McGlynn et 
al., 2003, Chan et al., 2009, Cromelin et al., 2018, Joshi et al., 2013). Another reason for 
exclusion was that the studies did not focus on mobile phone messaging (Ramasamy et al., 
2013, Nordmann et al., 2010, Boucher et al., 2008, Vengadesan et al., 2017, Owsley et al., 
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2015, Thavikulwat et al., 2015, Singh et al., 2000). Other studies were excluded because of 
ineligible study design. Only three studies used systematic review design (Ramke et al., 2017, 
Delphino et al., 2016, Kishiki et al., 2016). Two studies focused on group study design (Kowing 
et al., 2010, Yan et al., 2012). One study was excluded based on did not meet intervention 
criteria (Sanguansak et al., 2017). Only one study was excluded based on language of 
publication (Audugé et al., 1998). 
 
4.4. Study characteristics 
4.4.1 Participants 
In the ten included studies the total number of participants were 5399 [2183 male, 3216 
females] of which 59% were female. Most of the participants who took part in the review were 
from developing countries, 72% [3895] were from settings in LMIC, 89% [3458] were from 
China (Lin et al., 2012, Huang et al., 2012, Yang et al., 2016, Meltzer et al., 2017). The 
remaining 21% of the participants were from other developing countries including Tanzania 
(Mtuya et al., 2016), South Africa (Malherbe, 2017). The participants were all patients with 
ophthalmic diseases including cataract, glaucoma and diabetic retinopathy, who required 
treatment or surgery in order to avoid loss of vision. Participants in those studies were receiving 
mHealth reminders for follow-up cataract surgery appointments or treatment and adherence to 
glaucoma and diabetic retinopathy medication. Participants ethnicity varied; the following 
ethnic groups was represented in the study sample, White, Black, Colored, African and Asian. 
The age categories of these participants are [child - 0 to 20 years, young 20 to 40 years, adults 
40 to 60 years, old age over 60 years]. Only one study was found that included children under 
18 years. In this study parents received reminder messages on behalf of the children (Lin et al., 
2012). The mean age of all participants was [61.5 years]. Figure 2 on age distribution of the 
study participants per mHealth modality, shows the age groups of participants and mHealth 
interventions utilized. The figure shows that SMS intervention had the highest percentage 






Figure 2: Age distribution of study participants per mHealth modality 
 
The duration of studies was between 2 months and 2 years, with only one study conducted over 
a period of more than 2 years (Meltzer et al., 2017). Three studies were done in period of one 
year (Pizzi et al., 2016, Yang et al., 2016, Saeedi et al., 2015, Malherbe, 2017). The remaining 
studies took between 2 to 5 months (Koshy et al., 2008, Huang et al., 2012, Fudemberg et al., 
2016, Mtuya et al., 2016).  
The greatest sample size of participants was found in the cohort study by Meltzer, the sample 
size was 2316 participants (Meltzer et al., 2017). The remaining studies had a sample size 
between 80 and 1000 participants (Pizzi et al., 2016, Saeedi et al., 2015, Huang et al., 2012, 
Fudemberg et al., 2016, Lin et al., 2012, Yang et al., 2016, Sanguansak et al., 2017, Malherbe, 
2017).  
4.4.2 Interventions  
The main mHealth intervention modality used by participants was SMS (Mtuya et al., 2016, 
Lin et al., 2012, Koshy et al., 2008, Saeedi et al., 2015, Yang et al., 2016, Malherbe, 2017). 
Four out of ten studies used telephone call reminders (Pizzi et al., 2016, Huang et al., 2012, 
Meltzer et al., 2017, Fudemberg et al., 2016).  
4.4.3 Outcomes  
Four out of the ten included studies reported on the primary outcome of improving adherence 
and follow up to glaucoma appointments (Fudemberg et al., 2016, Pizzi et al., 2016, Saeedi et 
al., 2015, Yang et al., 2016). Another four out of ten studies reported on the primary outcome 
of  increased attendance to follow-up cataract surgery appointments (Lin et al., 2012, Meltzer 
















increased attendance to follow-up diabetic retinopathy appointments (Mtuya et al., 2016), one 
study reported improved attendance to ophthalmic outpatients appointments in general, with 
no specific diseases (Koshy et al., 2008). 
Five out of the ten studies reported the cost of the intervention ,where one study conducted in 
China reported that the cost of reminders was low  (US$0.02) per message (Yang et al., 2016).  
Another study conducted in USA reported that the cost of the intervention was US$11.32 per 
patient (Pizzi et al., 2016). One study conducted in South Africa reported the cost for three 
SMS reminder to be 54 cents (Malherbe, 2017). A study conducted in the UK reported that the 
cost of sending the reminder was 7.2 pence (Koshy et al., 2008). Onley one study conducted in 
China reported that the SMS reminder was free of charge (Lin et al., 2012). The remaining five 
studies out of the ten did not report on the cost of the intervention (Fudemberg et al., 2016, 
Huang et al., 2012, Mtuya et al., 2016, Meltzer et al., 2017, Saeedi et al., 2015). Summary on 
the characteristics of included studies are shown in  Table 3 below. 
21 
 
Characteristics of included studies 
  
 
Study ID  Study design, 
Country, Device 
Sample size Follow-up period  Age, gender  Interventions Outcomes 









Between April and June 2013. 50 to 80 years. 
Mean age 67.4 
Male & female 
 
Text messages were sent to inform 
patients about their screening, and 
mobile retinal image was used for 
eye examination  
Increase attendance to follow-up 
appointments  









1 September 2012 to 31 
October 2013. 
Over 65 years 
Male & female. 
Telephone call reminders used to 
call patients 2-3 days prior to the 
appointment and customized letter 
sent 2 weeks before appointment  
Improve adherence to glaucoma 
appointments  











Between February 2011 to 
January 2012. 
3 age group 
Under 40 
41 to 65. 
Over 65 years. 
[Mean age 68.0] 
 
Text message and Email were sent 
to glaucoma patients as reminder 
for appointment and medication  
Improving adherence to glaucoma 





trials. Country: South 
Africa. 




Between June 2015 
and June 2016. 




Automated SMS reminder system 
dispatched an SMS reminder one 
month, four days and one day 
preoperatively between 10am and 
12am 
Attendance rate with and without 
an SMS reminder system. 





Device: mobile phone 
209 participants. 
Female 209. 
Between October 1, 2014 to 
November 31,2015. 
Mean age 64.4 
intervention group 
 
Text message reminders were sent 
to patients 3 days before 
appointment  
















Between 1 September 2013 
and 30 November 2013  
> 21 years of age 
Mean age 64.4 in 
CPEC clinic,66.3 
in glaucoma clinic 
Male & female  
Telephone reminders were sent to 
patients attending a primary eye 
care clinic. 
Increase rate of adherence to 
follow-up appointments 








Female 277  
Over two 4 days periods 
Between October 11-14,2009 
and October 19-23,2009  
Mean age 74.1 ± 
8.8 years. 
Male & female 
 
Telephone and advertisements 
were used to invite patients 
underwent cataract surgery to 
hospital-based study examination  
Improving compliance with cataract 
surgery. 




Device: mobile phone 
9959 
participants 




SMS text messages were sent to 
patients with scheduled 
appointments at a hospital 
ophthalmology department in 
London.  
Improve attendance at 
ophthalmology outpatients 
appointments  









Information not available < 18 years  
Male & female. 
Automated SMS text message 
reminder was sent to parents of 
children before scheduled 
appointments  
Increase number of follow-up 
appointments 
 









From January 19,2010 to 
April 18,2012  
Mean age 68.4 
Male & female  
Telephone and transportation 
interventions were used to 
increase follow-up at least 40 days 
after cataract surgery 
Increase follow-up at least 40 days 




4.5. Risk of bias in included studies  
The risk of bias in four RCTs was assessed using a cochrane risk of bias tools. The risk of bias 









4.5.1 Allocation (selection bias) 
The random sequence generation was low in four randomized control studies, and all studies 
were described the randomization of allocation regarding of mHealth intervention reminder on 
attendance to ophthalmic diseases appointments. Where two studies applied random number 
generator program (Lin et al., 2012, Malherbe, 2017). The remaining two studies applied 
certain aspects of sequence generation methods such as simple randomization program (Yang 
et al., 2016). and recommended follow-up program (Pizzi et al., 2016).  
Allocation concealment was low risk in all randomized control studies (Lin et al., 2012, 
Malherbe, 2017, Pizzi et al., 2016, Yang et al., 2016). 
4.5.2 Blinding 
Blinding of participants (performance bias) were low risk in three studies (Pizzi et al., 2016, 
Malherbe, 2017, Lin et al., 2012).  Only one study participants were not blinded (Yang et al., 
2016).  
Blinding of outcomes (detection bias) were low in three studies (Yang et al., 2016, Malherbe, 
2017, Pizzi et al., 2016). Risk of bias was unclear in one study(Lin et al., 2012). 
 






Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
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4.5.3 Incomplete outcome data (attrition bias) 
Risk of attrition bias was low in two studies (Malherbe, 2017, Yang et al., 2016), while in 
remaining two studies risk of attrition bias was high. One RCT study on pediatric cataract 
treatment (Lin et al., 2012) had many participants that were lost during follow-up which made 
it impossible to determine whether there was a significant improvement on the outcomes. Also 
there was incomplete outcome data in one study (Pizzi et al., 2016) where approximately 30 % 
of patients were cancelled without rescheduling or simply do not show up for an appointment 
and were lost to follow-up. 
4.5.4 Selective reporting 
The risk of selective reporting was low in three studies (Malherbe, 2017, Lin et al., 2012, Yang 
et al., 2016), and unclear in one study. Study by Pizzi et al reported in the method of the study 
that one particular outcomes were not reported in the results (Pizzi et al., 2016). 
4.5.5 Other sources of bias 
There were no other possible sources of bias since none of the studies indicates there is 











4.5.6 Risk of bias in observational study  
Assessment of risk of bias in the remining six observational studies was assessed using the 
quality assessment tool by Hoy et al. 2012 that, is particularly used for observational studies 
design (Hoy et al., 2012). This tool shows the categorizes of risk as high risk for those studies 













The assessment of the risk of bias in observational studies was low in five (Fudemberg et al., 
2016, Huang et al., 2012, Meltzer et al., 2017, Mtuya et al., 2016, Saeedi et al., 2015), and was 
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1. Was the study's target population a…
2. Was the sampling frame a true or…
3. Was some form of random…
4. Was the likelihood of nonresponse…
5. Were data collected directly from…
6. Was an acceptable case definition…
7. Was the study instrument that…
8. Was the same mode of data…
9. Was the length of the shortest…
10. Were the numerator(s) and…




4.6. Results of individual studies 
Effect of the interventions. 
4.6.1 Effect of SMS reminder compared to conventional reminder. 
Analysis of  two RCT studies (Lin et al., 2012, Malherbe, 2017), shows that patients who had 
cataracts showed improvement in appointment attendance ( RR 1.26; 0.89, 1.78 ) compared to 
cataract patients that had used conventional methods as seen in Figure 5. 
 
 
Figure 5; Analysis of 2 RCTs that shows the effect of SMS reminder in cataract diseases 
 
 
One a cross sectional study shows that SMS reminder has difference on SMS reminder group 
compared to conventional methods. According to the study SMS has useful impact when used 
as reminder for patients with glaucoma disease as seen in Figure 6. 
 
 




Analysis of  non RCT study (Koshy et al., 2008), shows that the SMS reminder has no 
improvement on the SMS reminder group compared to conventional methods when used as 






Figure 7: Analysis of  non RCT study shows the effect of SMS reminder with ophthalmology outpatients 
appointments. 
 
Analysis of one a cross sectional study (Mtuya et al., 2016), shows that the SMS reminder had 
no improvements on the appointments of diabetic retinopathy compared to conventional 
methods as seen in Figure 8. 
 
 
Figure 8: Analysis of a cross sectional study shows the effect of SMS reminder with diabetic retinopathy. 
 
4.6.2 Effect of phone call reminder compared to conventional reminder. 
Analysis of two cohort studies (Huang et al., 2012, Meltzer et al., 2017), shows that the phone 
call reminder had no improvement in the attendance of cataract disease patients compared to 
conventional methods as seen in Figure 9. 
 
 




Analysis of one RCT study (Pizzi et al., 2016),  shows that the phone call reminder has very 
slight improvement among glaucoma patient as a method of appointment reminder compared 
to conventional methods as seen in Figure 10.    
 
 




















5. Chapter Five: Discussion, Conclusion and Recommendations 
The systematic review aimed to determine the impact of mobile phone messaging as a reminder 
to improve patient attendance to cataract surgery. This section discusses the results in the 
context of the aims and objectives of the study and provides a summary of the limitations of 
the study. Conclusions are drawn, and recommendations are made for further study. 
5.1. Discussion  
The systematic review aimed to determine the impact of mobile phone messaging as a reminder 
to improve patient attendance to cataract surgery. This section discusses the results in the 
context of the aims and objectives of the study and provides a summary of the limitations of 
the study. Conclusions are drawn, and recommendations are made for further study. 
A total of seventy studies was retrieved from our initial search. Once duplicates were removed 
and articles screened according to the eligibility criteria only ten articles remained. The ten 
articles varied substantially in relation to study design, settings and sample size. The literature 
and results from this review indicate that there is a lack of peer-reviewed studies that use 
mHealth as a reminder for cataract surgery. Furthermore, only four studies were included that 
met the gold standard of study designs which is RCTs (Lin et al., 2012, Yang et al., 2016, Pizzi 
et al., 2016, Malherbe, 2017). These four RCT studies addressed the use of mHealth 
intervention with cataracts and glaucoma diseases. Two studies were conducted in China (Lin 
et al., 2012, Yang et al., 2016) , the remaining two were in the USA (Pizzi et al., 2016) and 
South Africa (Malherbe, 2017). This confirms the assertion by Lin et al. (2012) that there are 
only a few studies in which mHealth was used for the management of cataracts. 
Participants of the study were all patients who had experienced ophthalmic diseases including 
cataracts, glaucoma and diabetic retinopathy as those particular disease has considered the most 
ophthalmic disease leading to blindness (Quillen, 1999, Pelletier et al., 2016). With regard to 
the location, 72% of the participants were from LMIC (Huang et al., 2012, Lin et al., 2012, 
Yang et al., 2016, Meltzer et al., 2017, Sanguansak et al., 2017, Mtuya et al., 2016) while 89% 
of these participants were from China (Lin et al., 2012, Huang et al., 2012, Yang et al., 2016, 
Meltzer et al., 2017). This confirms the prevalence of cataract diseases in these countries and 
the incidence of blindness associated with cataract. 
With regard to gender of participants, among the total number of participant of 5399, [2183 
male, 3216 females], females were 59% higher than males. eight studies in the review 
demonstrated a higher female participation rate. The literature also reported that, in many 
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developing countries the prevalence of ophthalmic disease such as cataract is higher in women 
compared to men (Thomas et al., 2016). 
With regards to the age of participants, 80% of the participants between 60 to 70 years of age 
utilized mHealth intervention the most (Lin et al., 2012, Yang et al., 2016, Pizzi et al., 2016, 
Malherbe, 2017, Fudemberg et al., 2016, Huang et al., 2012, Meltzer et al., 2017, Mtuya et al., 
2016, Saeedi et al., 2015) . This clearly demonstrates that most people over 65years of age have 
been affected by ophthalmic disease such as cataract, glaucoma and diabetic retinopathy in 
over the world. Literatures states that over 50% of American people have been diagnosed with 
cataract disease by the age of 70 years (Friedman, 2012). The evidence highlights that when 
targeting a particular group then age would be a key factor given the success among the 60 – 
70 years age group.  
With regard to mHealth reminder modalities, the results show that 60% of mHealth studies 
used SMS (Mtuya et al., 2016, Lin et al., 2012, Koshy et al., 2008, Saeedi et al., 2015, Yang et 
al., 2016, Malherbe, 2017). This statement confirms that text messaging is often used when 
evaluating the use of mHealth intervention in increases attendance or adherence to  
appointments or medications with diseases such as cataracts, glaucoma and diabetic 
retinopathy  (Lin et al., 2012, Saeedi et al., 2015, Mtuya et al., 2016). The use of SMS as 
reminder is regarded as the most beneficial tool; this is attributed to the cost effectiveness of 
the intervention compared to other mobile phone applications that require internet connectivity 
(Kaplan, 2006). Also, SMS have been reported to be more accessible to mobile phones users 
since they are able to use this modality (i.e. SMS) even when no voice calls are allowed or 
permitted (Balzer et al., 2014). 
The main outcome of interest in the systematic review study was improving patients’ 
attendance to ophthalmic diseases treatments compared to conventional reminders. Results 
from the study show that there was a significant difference in attendance rate for studies that 
used SMS reminders compared to telephone reminder studies (Lin et al., 2012, Koshy et al., 
2008, Yang et al., 2016, Saeedi et al., 2015, Mtuya et al., 2016, Malherbe, 2017). This gives a 
clear indication on the usability of SMS reminder on improving attendance to ophthalmic 
diseases appointments and adherence to medications. Literature also demonstrated that SMS 
has been found to be a feasible tool for use as a reminder system (Balzer et al., 2014). It has 
been reported that SMS reminders improve attendance rates for pediatric cataract treatments 
(Lin et al., 2012). Also, SMS has been reported to had improve adherence to glaucoma 
appointments (Saeedi et al., 2015).  
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The cost of the intervention has been reported in five studies that the cost was low, four of these 
studies was SMS reminder used (Koshy et al., 2008, Lin et al., 2012, Malherbe, 2017, Yang et 
al., 2016), although evaluation of the cost of interventions in this systematic review was the 
secondary outcomes. However, literature demonstrate that the SMS reminder has been found 
superior due to low operation costs compared with other mHealth modalities, on the other hand 
mobile phone call reminder has been found costly and time consuming (Malherbe, 2017).   
One of the limitations in the study was that only  four RCT studies were included in the 
systematic review and this adversely affects the reliability of the evidence regarding to the 
effect of the interventions (Lin et al., 2012, Pizzi et al., 2016, Yang et al., 2016, Malherbe, 
2017). In addition, one of the included studies addressed ophthalmology in general, focusing 
on outpatient appointments without specifying the particular disease. Also, there was missing 
data regarding the characteristics of participants such as age and gender (Koshy et al., 2008). 
 
5.2. Conclusions and recommendations 
The review has shown that mHealth interventions have a positive effect on patient attendance 
to follow-up appointments for ophthalmic disease including cataracts, glaucoma and diabetic 
retinopathy. This has been evident in the use of SMS as the most successful modality of 
mHealth reminders in comparison to other modalities such as phone. 
Many of the participants included in the review were from LMIC. In LMIC’s the prevalence 
of preventable blindness or blindness related to cataracts, glaucoma, and diabetic retinopathy 
is high. Also, eighty percent of the participants were older than 55 years and sixty percent were 
female. 
Given the potential that the study has shown for mHealth in the management of ophthalmic 
diseases, it is recommended that further research is given priority, especially in LMIC and on 
groups severely affected by ophthalmic diseases, such as women over the age of 55. Future 
studies should be conducted to determine the effectiveness of mHealth reminders applied 
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TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.   
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of key 
findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
1 
Objectives  4 Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, outcomes, 
and study design (PICOS).  
3 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
iv 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) 
and report characteristics (e.g., years considered, language, 




7 Describe all information sources (e.g., databases with dates of 
coverage, contact with study authors to identify additional studies) 
in the search and date last searched.  
12 
Search  8 Present full electronic search strategy for at least one database, 
including any limits used, such that it could be repeated.  
12 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, 





10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
13 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
13 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used in 




13 State the principal summary measures (e.g., risk ratio, difference 




14 Describe the methods of handling data and combining results of 
studies, if done, including measures of consistency (e.g., I2) for 





From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and  
Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the cumulative 




16 Describe methods of additional analyses (e.g., sensitivity or subgroup 
analyses, meta-regression), if done, indicating which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included 
in the review, with reasons for exclusions at each stage, ideally with a 




18 For each study, present characteristics for which data were extracted 
(e.g., study size, PICOS, follow-up period) and provide the citations.  
18 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, any outcome 





20 For all outcomes considered (benefits or harms), present, for each study: 
(a) simple summary data for each intervention group (b) effect estimates 




21 Present results of each meta-analysis done, including confidence 
intervals and measures of consistency.  
26 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across studies (see 




23 Give results of additional analyses, if done (e.g., sensitivity or subgroup 
analyses, meta-regression [see Item 16]).  
 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each 
main outcome; consider their relevance to key groups (e.g., healthcare 
providers, users, and policy makers).  
29 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at 
review-level (e.g., incomplete retrieval of identified research, reporting 
bias).  
31 
Conclusions  26 Provide a general interpretation of the results in the context of other 
evidence, and implications for future research.  
31 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support 




Appendix B: Search terms  
Cataract: Search Terms.  
#1 Search Pseudophakia. Items found 2585   
#2 Search Aphakia, Postcataract. Items found 1815   
#3 Search "Aphakia, Postcataract"[Mesh]. Items found 1810  
#4 Search "Lenses, Intraocular"[Mesh]. items found 3984  
#5 Search Lenses, Intraocular. items found 16020  
#6 Search cataract removal. items found 2563  
#7 Search cataract surgery. items found 44063  
#8 Search Cataract Extraction. items found 33435  
#9 Search "Cataract Extraction"[Mesh]. items found 31317  
#10 Search cataract. Items found 66506 
#11 Search "Cataract"[Mesh]. Items found 26842 
# 12 "Cataract"[Mesh]) OR cataract) OR "Cataract Extraction"[Mesh]) OR Cataract 
Extraction) OR cataract surgery) OR cataract removal) OR "Lenses, Intraocular"[Mesh]) OR 
Lenses, Intraocular) OR "Aphakia, Postcataract"[Mesh]) OR Aphakia, Postcataract) OR 
Pseudophakia. Items found 74510  
mhealth: Search Terms.  
#1 Reminder Systems. Items found 3649  
#2 "Reminder Systems"[Mesh]. Items found 3017 
#3 Whatsapp. Items found 141  
#4 Phone call. Items found 1806  
#5 telephone call. Items found 3215  
#6 Voice mail. Items found 355  
#7 short message service. Items found 3107  
#8 messaging. Items found. Items found 4843  
#9 texting. Items found 2999  
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#10 text messages. items found 3641  
#11Text Messaging. Items found 2743  
#12 "Text Messaging"[Mesh]. Items found 1818  
#13 Smartphone. Items found 5240  
#14 "Smartphone"[Mesh]. Items found 1652  
#15 mobile phones. Items found 11309  
#16 mobile telephone. Items found 10643  
#17 telephones. Items found 63602  
#18 cellular phone. Items found 10168  
#19 "Cell Phone"[Mesh]. Items found 8453  
#20 Cell Phones. Items found 10196  
#21 "Mobile Applications"[Mesh]. Items found 2727  
#22 Mobile Applications. items found 6688  
#23 Wireless Technology. Items found 5541  
#24 "Wireless Technology"[Mesh]. Items found 2659  
#25 mobile health. items found. 45705  
#26 mHealth. Items found 27720  
#27 "Telemedicine"[Mesh]. Items found 22157  
#28 telemedicine. Items found 26026  
# 29 ("Telemedicine"[Mesh]) OR telemedicine) OR mHealth) OR mobile health) OR 
"Wireless Technology"[Mesh]) OR Wireless Technology) OR "Mobile Applications"[Mesh]) 
OR Mobile Applications) OR "Cell Phone"[Mesh]) OR Cell Phones) OR cellular phone) OR 
telephones) OR mobile telephone) OR mobile phones) OR "Smartphone"[Mesh]) OR 
Smartphone) OR "Text Messaging"[Mesh]) OR Text Messaging) OR text messages) OR 
texting) OR messaging) OR short message service) OR Voice mail) OR telephone call) OR 
Phone call) OR Whatsapp) OR "Reminder Systems"[Mesh]) OR Reminder Systems. Items 
found 121851 . 
Attendance Search Terms  
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#1 Cost effectiveness[Title/Abstract]. Items found 50322  
#2 Adherence[Title/Abstract]. Items found 95870  
#3 Attendance[Title/Abstract]. Items found 21634  
#4 Lost to Follow-Up[Title/Abstract]. Items found 14459  
#5 "Lost to Follow-Up"[Mesh]. Items found 933  
#6 Patient non-attendance[Title/Abstract]. items found 28  
#7 No-Show Patients[Title/Abstract]. Items found 21  
#8 "No-Show Patients"[Mesh]. Items found 68  
#9 Patient Compliance[Title/Abstract]. Items found. 8374  
#10 "Patient Compliance"[Mesh]. Items found 67259  
#11 "Patient Compliance"[Mesh]) OR Patient Compliance[Title/Abstract]) OR "No-Show 
Patients"[Mesh]) OR No-Show Patients[Title/Abstract]) OR Patient non-
attendance[Title/Abstract]) OR "Lost to Follow-Up"[Mesh]) OR Lost to Follow-
Up[Title/Abstract]) OR Attendance[Title/Abstract]) OR Adherence[Title/Abstract]) OR Cost 
effectiveness[Title/Abstract]. items found 228365. 
 
PubMed Search Terms: items found 17 
(((((((((((((((((("Cataract"[Mesh]) OR Cataract) OR "Cataract Extraction"[Mesh]) OR Cataract 
Extraction) OR cataract surgery) OR cataract removal) OR "Lenses, Intraocular"[Mesh]) OR 
Lenses, Intraocular) OR "Aphakia, Postcataract"[Mesh]) OR Aphakia, Postcataract) OR 
"Pseudophakia"[Mesh]) OR Pseudophakia)))))  
AND  
((((((((((((((((((((((((((((((("Telemedicine"[Mesh]) OR Telemedicine) OR mHealth) OR mobile 
health) OR "Wireless Technology"[Mesh]) OR Wireless Technology) OR "Mobile 
Applications"[Mesh]) OR Mobile Applications) OR "Cell Phones"[Mesh]) OR Cell Phones) 
OR cellular phone) OR telephones) OR mobile telephone) OR mobile phones) OR 
"Smartphone"[Mesh]) OR Smartphone) OR "Text Messaging"[Mesh]) OR Text Messaging) 
OR text messages) OR textings) OR messaging) OR short message service) OR voice mail) 
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OR telephone call) OR phone call) OR Whatsapp) OR "Reminder Systems"[Mesh]) OR 
Reminder Systems) OR Reminder)))))  
AND  
(((((((((((("Patient Compliance"[Mesh]) OR Patient Compliance[Title/Abstract]) OR "No-
Show Patients"[Mesh]) OR No-Show Patients[Title/Abstract]) OR Patient Non-
Attendance[Title/Abstract]) OR "Lost to Follow-Up"[Mesh]) OR Lost to Follow-
Up[Title/Abstract]) OR Attendance[Title/Abstract]) OR adherence[Title/Abstract])) OR cost 
effectiveness[Title/Abstract]) 
Web of Science Search Terms: items found 25 
TOPIC: (: (Cataract OR Cataract Extraction OR cataract surgery OR cataract removal OR 
Lenses Intraocular OR Aphakia Postcataract OR Pseudophakia))  
AND  
TOPIC: ((Telemedicine OR mHealth OR mobile health OR Wireless Technology OR Mobile 
Applications OR Cell Phone OR cellular phone OR telephones OR mobile telephone OR 
mobile phones OR Smartphone OR Text Messaging OR text messages OR texting OR 
messaging OR short message service OR voice mail OR telephone call OR phone call OR 
Whatsapp OR Reminder Systems OR Reminder)). 
 AND  
TOPIC: (: (Patient Compliance OR No-Show Patients OR Patient Non-Attendance OR Lost to 
Follow-Up OR Attendance OR adherence OR cost effectiveness)).  
Ebscohost Search Terms: items found 2  
Boolean/Phrase:( Cataract OR Cataract Extraction OR cataract surgery OR cataract removal 
OR Lenses Intraocular OR Aphakia Postcataract OR Pseudophakia)  
AND  
Boolean/Phrase (Telemedicine OR mHealth OR mobile health OR Wireless Technology OR 
Mobile Applications OR Cell Phone OR cellular phone OR telephones OR mobile telephone 
OR mobile phones OR Smartphones OR Text Messaging OR text messages OR texting OR 
messaging OR short message service OR voice mail OR telephone call OR phone call OR 




Boolean/Phrase:( Patient Compliance OR No-Show Patients OR Patient Non Attendance OR 
Lost to Follow-Up OR Attendance OR adherence OR cost effectiveness )  
Scopus Search Terms 
TITLE-ABS-KEY (Cataract OR “Cataract Extraction” OR “cataract surgery” OR “cataract 
removal” OR “Lenses Intraocular” OR “Aphakia Postcataract” OR Pseudophakia).  
AND  
TITLE-ABS-KEY (Telemedicine OR mHealth OR “mobile health” OR “Wireless 
Technology” OR “Mobile Applications” OR “Cell Phone” OR “cellular phone” OR telephones 
OR “mobile telephone” OR “mobile phones” OR “Smartphones” OR “Text Messaging” OR 
“text messages” OR texting OR messaging OR “short message service” OR “voice mail” OR 
“telephone call” OR “phone call” OR WhatsApp OR “Reminder Systems” OR reminder).  
AND  
TITLE-ABS-KEY (“Patient Compliance” OR “No-Show Patients” OR “Patient Non- 
Attendance” OR “Lost to Follow-Up” OR Attendance OR adherence OR “cost effectiveness”)  
Grey literature Search Terms: 
Google.com: 
mobile phone, messaging, reminder, cataract surgery. Items found 3  
Open Grey: 
mobile phone, messaging, reminder, cataract surgery. Items found 0. 
New York Academy of Medicine: 
mobile phone, messaging, reminder, cataract surgery. Items found 0. 
World Health Organization WHO: 
mobile phone, messaging, reminder, cataract surgery. Items found 0. 
Cochran Library:  
mobile phone, messaging, reminder, cataract surgery. Items found 1 
Cochrane Central Register of Controlled Trials: 
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• Sample size: 
Intervention population sample (#) 
Control population sample (#) 
 
 
• Duration of study: 
In months, divide by pre- and post- 
 
• Study design type: 








• Modality of mHealth 
• SMS 
• APP 
• Telephone call 
• USSD 
 
• Main outcome measures: 
Cataract Surgery Attendance 








Appendix D: Excluded studies 
No Study intervention Reason for excluded 
1 RP Gale et al.,2004 Telephone 
questionnaire  
The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
2 RP Gale et al.,2006 Telephone 
questionnaire  
The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
3 Lin et al 2016 Telephone interview The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
4 C. Drews-Botsch et al. 
2016 
Telephone interviews The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
5 SR Lambert et al 2016 Telephone interview The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
6 Norregaard et al 2007 Telephone interview The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
7 Hoffman et al 2016 Telephone interview The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
8 Ramasamy et al 2013 direct ophthalmoscopy The study did not address mobile phone messaging.  
9 Kowing et al., 2010 Telephone call 
reminder system 
The study design was a focus group study. 
10 Audugé et al 1998 Information not 
available 
The study was not published in English. 
11 Nordmann et al., 2010 A computerized device 
(Travalert® 
The study did not address mobile phone messaging.  
12 Boucher et al.,2008 mobile screening 
imaging 
The study did not address mobile phone messaging.  
13 Vengadesan et al 
(2017) 
No intervention  The study did not address mobile phone messaging.  
14 Owsley et al., 2015 nonmydriatic camera The study did not address mobile phone messaging. 
15 Yan et al., 2012 telephone or short 
message to remind 
The study design was a focus group study. 
16 Thavikulwat et al 2015 No intervention The study did not address mobile phone messaging. 
17 McGlynn et al 2003 Telephone interview  The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
18 Chan et al 2009 Telephone interview The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
19 Cromelin et al (2018) Telephone interview The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
20 Joshi et al 2013 telephone 
questionnaire 
The intervention was not used as a reminder, study 
did not measure our outcomes of interest. 
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21 Remke J et al 2017 Telephone call Systematic review study. 
22 Delphino et al 2016 Phone Monitoring Systematic review study. 
23 E Kishiki et al 2016 Cell phone reminder Systematic review study. 
24 AJ Singh et al., 2000 No intervention The study did not address mobile phone messaging.  
25 Sanguansak et al, 2017 Multimedia message   did not meet mHealth interventions criteria   
 
 
